$GXAI
GAXOS.AI INC. Stock $gxai

$gxai Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000121390024042974 Filed on May 14, 2024

Income Statement

Concept	2024 Q2	2024 Q1	2023 Q1
Revenue		$19.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin		$861.5K	$77.50K
YoY Change		1011.61%	-50.86%
% of Gross Profit
Research & Development	$249.3K	$182.3K	$104.6K
YoY Change	-6.83%	74.39%	-30.53%
% of Gross Profit
Depreciation & Amortization	$14.15K	$8.700K	$3.140K
YoY Change	124.96%	177.07%
% of Gross Profit
Operating Expenses	$854.5K	$1.044M	$1.542M
YoY Change	11.18%	-32.32%	400.42%
Operating Profit	-$854.5K	-$1.044M	-$1.542M
YoY Change	11.18%	-32.32%	400.42%
Interest Expense		$131.7K	$6.300K
YoY Change		1990.48%	1602.7%
% of Operating Profit
Other Income/Expense, Net	$45.27K	$131.7K	$6.301K
YoY Change	210.95%	1990.05%	1598.38%
Pretax Income		-$912.2K	-$1.536M
YoY Change		-40.61%	398.97%
Income Tax
% Of Pretax Income
Net Earnings	-$809.2K	-$912.1K	-$1.536M
YoY Change	7.32%	-40.62%	398.97%
Net Earnings / Revenue		-4800763.16%
Basic Earnings Per Share	-$0.72	-$0.91	-$0.14
Diluted Earnings Per Share	-$0.72	-$0.91	-$0.14
COMMON SHARES
Basic Shares Outstanding	1.094M shares	1.094M shares	12.10M shares
Diluted Shares Outstanding	1.120M shares	1.006M shares	11.26M shares

Balance Sheet

Concept	2024 Q2	2024 Q1	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$4.671M	$5.404M	$5.723M
YoY Change	-10.48%	-5.56%	209.48%
Cash & Equivalents	$2.372M	$3.312M	$2.213M
Short-Term Investments	$2.299M	$2.092M	$3.509M
Other Short-Term Assets	$216.8K	$360.9K	$165.5K
YoY Change	85.94%	118.04%	86.84%
Inventory
Prepaid Expenses
Receivables		$10.00
Other Receivables		$0.00
Total Short-Term Assets	$4.888M	$5.765M	$5.888M
YoY Change	-8.37%	-2.09%	203.87%
LONG-TERM ASSETS
Property, Plant & Equipment	$63.07K	$67.73K
YoY Change
Goodwill
YoY Change
Intangibles		$147.5K	$55.51K
YoY Change		165.74%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$203.1K	$216.0K	$55.51K
YoY Change		289.22%
TOTAL ASSETS
Total Short-Term Assets	$4.888M	$5.765M	$5.888M
Total Long-Term Assets	$203.1K	$216.0K	$55.51K
Total Assets	$5.091M	$5.981M	$5.944M
YoY Change	-4.57%	0.63%	206.74%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$297.7K	$393.2K	$125.6K
YoY Change	63.17%	212.99%	0.08%
Accrued Expenses	$94.45K	$120.6K	$23.66K
YoY Change	-0.11%	409.73%	80.64%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$392.1K	$513.8K	$149.3K
YoY Change	41.57%	244.18%	7.69%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$392.1K	$513.8K	$149.3K
Total Long-Term Liabilities	$0.00	$0.00	$0.00
Total Liabilities	$392.1K	$513.8K	$149.3K
YoY Change	41.57%	244.18%	7.69%
SHAREHOLDERS EQUITY
Retained Earnings	-$7.103M	-$6.294M	-$2.969M
YoY Change	90.76%	111.95%
Common Stock	$120.00	$109.00	$1.210K
YoY Change	-90.06%	-90.99%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$4.699M	$5.468M	$5.794M
YoY Change
Total Liabilities & Shareholders Equity	$5.091M	$5.981M	$5.944M
YoY Change	-4.57%	0.63%	206.74%

Cashflow Statement

Concept	2024 Q2	2024 Q1	2023 Q1
OPERATING ACTIVITIES
Net Income	-$809.2K	-$912.1K	-$1.536M
YoY Change	7.32%	-40.62%	398.97%
Depreciation, Depletion And Amortization	$14.15K	$8.700K	$3.140K
YoY Change	124.96%	177.07%
Cash From Operating Activities	-$738.5K	-$1.099M	-$933.9K
YoY Change	-48.5%	17.73%	403.67%
INVESTING ACTIVITIES
Capital Expenditures	$2.010K	$171.3K
YoY Change
Acquisitions
YoY Change
Other Investing Activities	-$200.0K	$520.9K	-$3.491M
YoY Change	-94.27%	-114.92%
Cash From Investing Activities	-$202.0K	$349.6K	-$3.491M
YoY Change	-94.21%	-110.01%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	90.00	$3.037M	$5.958M
YoY Change	-100.0%	-49.02%	-13753.69%
NET CHANGE
Cash From Operating Activities	-738.5K	-$1.099M	-$933.9K
Cash From Investing Activities	-202.0K	$349.6K	-$3.491M
Cash From Financing Activities	90.00	$3.037M	$5.958M
Net Change In Cash	-940.4K	$2.288M	$1.533M
YoY Change	-193.19%	49.19%	-769.45%
FREE CASH FLOW
Cash From Operating Activities	-$738.5K	-$1.099M	-$933.9K
Capital Expenditures	$2.010K	$171.3K
Free Cash Flow	-$740.5K	-$1.271M
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.64
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	938435	shares
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1024710	usd
CY2024Q1	dei	Document Type DocumentType	10-Q
CY2024Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2024Q1	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2024Q1	dei	Entity File Number EntityFileNumber	001-41620
CY2024Q1	dei	Entity Registrant Name EntityRegistrantName	GAXOS.AI INC.
CY2024Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2024Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	87-3288897
CY2024Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	101 Eisenhower Pkwy, Suite 300
CY2024Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Roseland
CY2024Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	NJ
CY2024Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	07068
CY2024Q1	dei	City Area Code CityAreaCode	(973)
CY2024Q1	dei	Local Phone Number LocalPhoneNumber	275-7428
CY2024Q1	dei	Security12b Title Security12bTitle	Common Stock, par value $0.0001 per share
CY2024Q1	dei	Trading Symbol TradingSymbol	GXAI
CY2024Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2024Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2024Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2024Q1	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2024Q1	dei	Entity Shell Company EntityShellCompany	false
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	1093672	shares
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3312277	usd
CY2024Q1	us-gaap	Short Term Investments ShortTermInvestments	2092078	usd
CY2023Q4	us-gaap	Short Term Investments ShortTermInvestments	2592689	usd
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	10	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	8	usd
CY2024Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	360913	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	25132	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	5765278	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	3642539	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	67733	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	52606	usd
CY2024Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	147500	usd
CY2024Q1	gxai	Digital Currencies DigitalCurrencies	801	usd
CY2023Q4	gxai	Digital Currencies DigitalCurrencies	801	usd
CY2024Q1	us-gaap	Assets Noncurrent AssetsNoncurrent	216034	usd
CY2023Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	53407	usd
CY2024Q1	us-gaap	Assets Assets	5981312	usd
CY2023Q4	us-gaap	Assets Assets	3695946	usd
CY2024Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	393150	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	215882	usd
CY2024Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	120623	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	54154	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	513773	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	270036	usd
CY2024Q1	us-gaap	Liabilities Liabilities	513773	usd
CY2023Q4	us-gaap	Liabilities Liabilities	270036	usd
CY2024Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1093672	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1093672	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	988368	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	988368	shares
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	109	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	99	usd
CY2024Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	11764728	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	8711550	usd
CY2024Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-3629	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	95785	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-6293669	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-5381524	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	5467539	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	3425910	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	5981312	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3695946	usd
CY2024Q1	us-gaap	Revenues Revenues	19	usd
CY2024Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	182329	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	104551	usd
CY2024Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	861529	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1437781	usd
CY2024Q1	us-gaap	Operating Expenses OperatingExpenses	1043858	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	1542332	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-1043839	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-1542332	usd
CY2024Q1	us-gaap	Interest And Other Income InterestAndOtherIncome	11979	usd
CY2023Q1	us-gaap	Interest And Other Income InterestAndOtherIncome	6301	usd
CY2024Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	119715	usd
CY2024Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	131694	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	6301	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-912145	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-1536031	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-912145	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-1536031	usd
CY2024Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-99415	usd
CY2023Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	18156	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1011560	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1517875	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.91
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.64
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1005558	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	938435	shares
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	3425910	usd
CY2024Q1	gxai	Stock Issued During Period Common And Warrant Value StockIssuedDuringPeriodCommonAndWarrantValue	159060	usd
CY2024Q1	gxai	Adjustments To Additional Paid In Capital Prefunded Warrants For Cash AdjustmentsToAdditionalPaidInCapitalPrefundedWarrantsForCash	2897924	usd
CY2024Q1	gxai	Stock Issued During Period Value Purchase And Cancellation Of Treasury Stock StockIssuedDuringPeriodValuePurchaseAndCancellationOfTreasuryStock	-19602	usd
CY2024Q1	gxai	Adjustments To Additional Paid In Capital Accretion Of Stock Option Expense AdjustmentsToAdditionalPaidInCapitalAccretionOfStockOptionExpense	15806	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-99414	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-912145	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	5467539	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	685733	usd
CY2023Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	5755871	usd
CY2023Q1	gxai	Adjustments To Additional Paid In Capital Accretion Of Stock Option Expense AdjustmentsToAdditionalPaidInCapitalAccretionOfStockOptionExpense	870572	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	18156	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-1536031	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	5794301	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-912145	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-1536031	usd
CY2024Q1	us-gaap	Adjustment For Amortization AdjustmentForAmortization	8683	usd
CY2023Q1	us-gaap	Adjustment For Amortization AdjustmentForAmortization	3142	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	15806	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	870572	usd
CY2024Q1	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	119715	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2	usd
CY2024Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	335781	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	165123	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	177268	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-119399	usd
CY2024Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	66469	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	12981	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1099417	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-933858	usd
CY2024Q1	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	2095707	usd
CY2023Q1	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	3491242	usd
CY2024Q1	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	2616619	usd
CY2024Q1	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	21310	usd
CY2024Q1	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	150000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	349602	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3491242	usd
CY2024Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	159060	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	5958470	usd
CY2024Q1	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	2897924	usd
CY2024Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	19602	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3037382	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	5958470	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	2287567	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	1533370	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1024710	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	679781	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3312277	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2213151	usd
CY2023Q1	gxai	Reclassification Of Deferred Offering Costs To Equity ReclassificationOfDeferredOfferingCostsToEquity	202599	usd
CY2024Q1	gxai	Unrealizedloss Income On Shortterm Investments UnrealizedlossIncomeOnShorttermInvestments	-99414	usd
CY2023Q1	gxai	Unrealizedloss Income On Shortterm Investments UnrealizedlossIncomeOnShorttermInvestments	18156	usd
CY2024Q1	us-gaap	Nature Of Operations NatureOfOperations	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 1 – <span style="text-decoration:underline">NATURE OF OPERATIONS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gaxos.ai Inc. (formerly The NFT Gaming Company, Inc.) (the “Company”) was incorporated in the state of Wyoming on October 27, 2021 (“Inception”). On March 30, 2022, the Company reincorporated to the State of Delaware pursuant to a Plan of Conversion approved by the Board of Directors and a majority of the shareholders. On January 5, 2024, the Company changed its name from The NFT Gamimg Company, Inc. to Gaxos.ai Inc. The Company develops, designs, acquires, and manages games that offer affordable non-fungible tokens (NFTs) for unique and exclusive features, rewards, and opportunities. In addition to developing proprietary games, the Company’s platform will onboard third-party game publishers and provide access to blockchain and NFT architecture, product experiences, exclusive content, and revenue opportunities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 9, 2024, the Staff notified the Company that it has not regained compliance with Listing Rule 5550(a)(2) and was not eligible for a second 180-day period (the “Delisting Determination”). Further, unless the Company requested an appeal of the Delisting Determination to a Hearings Panel (the “Panel”), the Company’s securities would be scheduled for delisting from The Nasdaq Capital Market.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In early January 2024, the Company submitted a request to the Panel to appeal the Delisting Determination, and on January 16, 2024, the Panel notified the Company that it received the request which stayed the suspension of the Company’s securities and the filing of the Form 25-NSE, pending the Hearing Panel’s final written decision. On March 22, 2024, the Company received written notice from the Panel that the Company regained compliance with the minimum bid price requirement under NASDAQ Listing Rule 5550(a)(2) for continued listing on the Nasdaq Capital Market.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On February 28, 2024, a majority of the Company shareholders granted discretionary authority to the Company’s Board of Directors to amend the Company’s Certificate of Incorporation to effect one or more consolidations of the Company’s issued and outstanding shares of common stock, pursuant to which the shares of common stock would be combined and reclassified into on the basis of one share of common stock for each 12 shares of the Company’s common stock then issued and outstanding (the “Reverse Stock Split”). On March 7, 2024, the Company filed a Certificate of Amendment to the Amended and Restated Articles of Incorporation (the “Certificate of Amendment”) with the Secretary of State of the State of Delaware to effect a 1-for-12 reverse stock split with respect to the outstanding shares of the Company’s common stock. The Certificate of Amendment and the reverse stock split became effective on March 7, 2024. All share and per share data in the accompanying financial statements have been retroactively adjusted to reflect the effect of the Reverse Stock Split.</span></p>
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3312277	usd
CY2024Q1	us-gaap	Short Term Investments ShortTermInvestments	2092078	usd
CY2024Q1	gxai	Working Capital WorkingCapital	5251505	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1099417	usd
CY2023Q1	us-gaap	Gain On Sale Of Investments GainOnSaleOfInvestments	0	usd
CY2024Q1	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Use of Estimates</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0in 0in 0in 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the unaudited financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates in the accompanying unaudited financial statements include valuation of intangible assets and other long-lived assets, estimates of deferred tax valuation allowances and the fair value of stock options issued for services.</span></p>
CY2024Q1	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	10	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	8	usd
CY2024Q1	gxai	Unrealizedloss Income UnrealizedlossIncome	-99015	usd
CY2023Q1	gxai	Unrealizedloss Income UnrealizedlossIncome	18156	usd
CY2024Q1	us-gaap	Gain On Sale Of Investments GainOnSaleOfInvestments	119715	usd
CY2024Q1	gxai	Units Of Polygon Matic UnitsOfPolygonMatic	1552.78	pure
CY2023Q4	gxai	Units Of Polygon Matic UnitsOfPolygonMatic	1553.37	pure
CY2024Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1880057	shares
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	49578	shares
CY2024Q1	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	2095707	usd
CY2024Q1	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	-3629	usd
CY2024Q1	us-gaap	Debt Securities Available For Sale And Held To Maturity Fair Value DebtSecuritiesAvailableForSaleAndHeldToMaturityFairValue	2092078	usd
CY2023Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	2496904	usd
CY2023	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	95785	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale And Held To Maturity Fair Value DebtSecuritiesAvailableForSaleAndHeldToMaturityFairValue	2592689	usd
CY2024Q1	us-gaap	Property Plant And Equipment Useful Life PropertyPlantAndEquipmentUsefulLife	P3Y
CY2024Q1	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	78281	usd
CY2023Q4	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	56971	usd
CY2024Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	10548	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	4365	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	67733	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	52606	usd
CY2024Q1	us-gaap	Regulatory Asset Amortization Period RegulatoryAssetAmortizationPeriod	P36M
CY2024Q1	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	6183	usd
CY2023Q1	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	0	usd
CY2024Q1	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P5Y
CY2024Q1	us-gaap	Finite Lived License Agreements Gross FiniteLivedLicenseAgreementsGross	150000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	2500	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	147500	usd
CY2023	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	52363	usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	52363	usd
CY2024Q1	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	150000	usd
CY2024Q1	gxai	Purchase Price Amount PurchasePriceAmount	150000	usd
CY2024Q1	gxai	Installments Amount InstallmentsAmount	37500	usd
CY2023Q1	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P5Y
CY2024Q1	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P5Y
CY2024Q1	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	2500	usd
CY2023Q1	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	3142	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	30000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	30000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	30000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	30000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	27500	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	147500	usd
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2024Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	500000	shares
CY2022Q4	us-gaap	Deferred Offering Costs DeferredOfferingCosts	202599	usd
CY2024Q1	gxai	Percentage Of Wainwright Fee Expense PercentageOfWainwrightFeeExpense	0.075	pure
CY2024Q1	gxai	Percentage Of Management Fee Expense PercentageOfManagementFeeExpense	0.01	pure
CY2024Q1	gxai	Percentage Of Common Stock Underlying Warrant That Were Exercised PercentageOfCommonStockUnderlyingWarrantThatWereExercised	0.075	pure
CY2022Q1	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	208333	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	33333	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Expiration Date ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate	2033-02-14
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Description ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription	The options vest as to (i) 28,333 of such options on February 14, 2023; and (ii) the remaining 5,000 options vest quarterly (417 each quarter) beginning on May 14, 2023 and each quarter thereafter through February 14, 2026.
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	1023290	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	5000	shares
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	33972	usd
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted	6249	shares
CY2024Q1	us-gaap	Stock Option Exercise Price Increase StockOptionExercisePriceIncrease	6
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	33880	usd
CY2024Q1	gxai	Amount Of Annual Cash Fee Proceed AmountOfAnnualCashFeeProceed	40000	usd
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P3Y
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	1.846	pure
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0432	pure
CY2024Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	15806	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	870572	usd
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Vested SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested	138982	usd
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P1Y9M
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	875	usd
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q1	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2024Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2024Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2023Q1	us-gaap	Revenues Revenues		usd
CY2023Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments		usd
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.91
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1005558	shares
CY2023Q1	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses		usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable		usd
CY2023Q1	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments		usd
CY2023Q1	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware		usd
CY2023Q1	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets		usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants		usd
CY2023Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock		usd
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2024Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2024Q1	gxai	Reclassification Of Deferred Offering Costs To Equity ReclassificationOfDeferredOfferingCostsToEquity		usd
CY2023Q4	us-gaap	Finite Lived License Agreements Gross FiniteLivedLicenseAgreementsGross		usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization		usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet		usd
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate		pure
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate		pure
CY2024Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2024Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2024Q1	dei	Amendment Flag AmendmentFlag	false
CY2024Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2024Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2024Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001895618

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
0001213900-24-042974-index-headers.html	Edgar Link	pending
0001213900-24-042974-index.html	Edgar Link	pending
0001213900-24-042974.txt	Edgar Link	pending
0001213900-24-042974-xbrl.zip	Edgar Link	pending
ea0205164-10q_gaxosai.htm	Edgar Link	pending
ea020516401ex31-1_gaxosai.htm	Edgar Link	pending
ea020516401ex31-2_gaxosai.htm	Edgar Link	pending
ea020516401ex32-1_gaxosai.htm	Edgar Link	pending
ea020516401ex32-2_gaxosai.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
gxai-20240331.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
gxai-20240331_cal.xml	Edgar Link	unprocessable
gxai-20240331_def.xml	Edgar Link	unprocessable
gxai-20240331_lab.xml	Edgar Link	unprocessable
gxai-20240331_pre.xml	Edgar Link	unprocessable
ea0205164-10q_gaxosai_htm.xml	Edgar Link	completed
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$GXAI
GAXOS.AI INC. Stock $gxai

2024 Q2 Form 10-Q Financial Statement

#000121390024042974 Filed on May 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GXAI GAXOS.AI INC. Stock $gxai

2024 Q2 Form 10-Q Financial Statement

#000121390024042974 Filed on May 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GXAI
GAXOS.AI INC. Stock $gxai